David Neal Biography and Net Worth

Director of Aclarion

Mr. Neal has been on the Aclarion Board of Directors since September 2016. He is the founder and a current member of SC Capital 1 LLC, a securitized LLC formed to invest in breakthrough medical technologies and therapies. He is also a partner of Frontier Wealth Enterprises, LLC a financial services firm providing advice-based financial services to high net-worth families. He has held various positions with UBS, including Portfolio Manager and Regional Office Manager in Wichita Kansas. He was on the Hutchinson Regional Medical Center Board of Directors for 9 years and currently sits on the boards of The Cosmosphere, a world-class space museum & STEM education center, and the Hutchinson Community Foundation.

In 2007, Mr. Neal and his wife, Karin, started the John & Michael Neal Foundation for Cancer Research to raise money to help fund research for cancer research and breakthrough medical technologies across the globe. He holds a Bachelor of Sport Science degree from the University of Kansas and a Master of Management Science degree from the John Cook School of Business at Saint Louis University.

What is David K. Neal's net worth?: The estimated net worth of David K. Neal is at least $71.01 thousand as of August 13th, 2026. Neal owns 30,002 shares of Aclarion stock worth more than $71,015 as of October 8th. This net worth evaluation does not reflect any other investments that Neal may own. Learn More about David K. Neal's net worth.
How do I contact David K. Neal?: The corporate mailing address for Neal and other Aclarion executives is 8181 Arista Place, Ste 100, Broomfield, CO, 80021. Aclarion can also be reached via phone at 833-275-2266. Learn More on David K. Neal's contact information.
Has David K. Neal been buying or selling shares of Aclarion?: David K. Neal has not been actively trading shares of Aclarion within the last three months. Most recently, on Thursday, August 13th, David K. Neal bought 7,500 shares of Aclarion stock. The stock was acquired at an average cost of $2.40 per share, with a total value of $18,000.00. Following the completion of the transaction, the director now directly owns 30,002 shares of the company's stock, valued at $72,004.80. Learn More on David K. Neal's trading history.
Who are Aclarion's active insiders?: Aclarion's insider roster includes Ryan Bond (Chief Strategy Officer), Scott Breidbart (Director), Gregory Gould (CFO), Gregory Gould (CFO), David Neal (Director), Brent Ness (CEO), Brent Ness (Chief Executive Officer, President, and Director), William Wesemann (Director), and Amanda Williams (Director). Learn More on Aclarion's active insiders.
Are insiders buying or selling shares of Aclarion?: During the last twelve months, Aclarion insiders bought shares 11 times. They purchased a total of 67,888 shares worth more than $176,647.43. The most recent insider tranaction occured on August, 17th when Director Amanda M Williams bought 5,857 shares worth more than $15,989.61. Insiders at Aclarion own 0.0% of the company. Learn More about insider trades at Aclarion.
Information on this page was last updated on 8/17/2026.

David K. Neal Insider Trading History at Aclarion

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
8/13/2026	Buy	7,500	$2.40	$18,000.00	30,002
5/11/2026	Buy	2,500	$3.10	$7,750.00	2,502

David K. Neal Buying and Selling Activity at Aclarion

Aclarion Company Overview

Aclarion, Inc., a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. It develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was incorporated in 2008 and is based in Broomfield, Colorado.

Today's Range

Now: $2.35

$2.32

$2.41

50 Day Range

MA: $2.46

$2.02

$2.94

2 Week Range

Now: $2.35

$1.95

$12.03

Volume

21,449 shs

Average Volume

325,158 shs

Market Capitalization

$6.76 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.2